Market Overview:

The PET-CT scanner device market is experiencing rapid growth, driven by rising prevalence of chronic diseases, technological advancements in imaging, and expansion of healthcare infrastructure in emerging markets. According to IMARC Group's latest research publication, "PET-CT Scanner Devices Market Report: By Type (Stationary Scanners, Portable/Mobile Scanners), By Number of Slices (Low-Slice Scanners (< 64 Slices), Medium Slice Scanners (64 Slices), High-Slice Scanners (> 64 Slices)), by Isotope and Detector Type (Fluorodeoxyglucose (FDG), 62Cu ATSM, 18F Sodium Fluoride, FMISO, Gallium, Thallium, and Others), by Service Provider (Hospitals, Diagnostic Centers, Research Institutes), Application (Oncology, Neurology, Cardiology, and Others), and by Region 2025-2033." The global PET-CT scanner device market size reached USD 2.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.2 Billion by 2033, exhibiting a growth rate (CAGR) of 3.44% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Download a sample PDF of this report: https://www.imarcgroup.com/insurtech-market/requestsample

Our report includes: 

• Market Dynamics
• Market Trends And Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the PET-CT Scanner Device Market

• Rising Prevalence of Chronic Diseases:

The increasing incidence of chronic diseases, particularly cancer, neurological disorders, and cardiovascular conditions, is a significant driver of the PET-CT scanner device market. These conditions require precise diagnostic tools for early detection and effective treatment planning. PET-CT scanners combine functional and anatomical imaging, enabling clinicians to identify abnormalities at a cellular level, which is critical for diseases like cancer. For instance, in oncology, PET-CT scanners are indispensable for staging and monitoring cancer progression, as seen in hospitals like Kokilaben Dhirubhai Ambani Hospital in India, which adopted the Biograph 64, Vision 600 PET-CT scanner to enhance early cancer detection. This growing disease burden, coupled with an aging global population, fuels demand for advanced imaging technologies.

• Technological Advancements in Imaging:

Innovations in PET-CT technology, such as improved detector systems and artificial intelligence (AI) integration, are propelling market growth. Advanced systems like Siemens Healthineers’ Biograph Vision.X, with its high-resolution lutetium oxyorthosilicate (LSO) crystals and silicon photomultipliers, offer enhanced image clarity and reduced scan times. These improvements allow for faster, more accurate diagnoses while minimizing patient radiation exposure. Additionally, AI-driven image analysis enhances diagnostic precision by automating abnormality detection. Such advancements attract healthcare providers seeking cutting-edge solutions, as demonstrated by United Imaging’s uMI 780, which integrates AI for streamlined workflows, making PET-CT scanners a cornerstone of modern diagnostics.

• Expansion of Healthcare Infrastructure in Emerging Markets:

The growth of healthcare infrastructure in emerging regions like Asia-Pacific and Latin America is a key factor driving the PET-CT scanner market. Countries such as China and India are investing heavily in medical facilities, increasing the availability of advanced diagnostic tools. For example, China’s rising cancer rates have spurred demand for PET-CT systems to support timely diagnosis and treatment planning. Government initiatives and private investments in these regions are improving access to imaging technologies, particularly in diagnostic centers offering cost-effective services. This expansion not only broadens the market but also addresses the unmet diagnostic needs of large populations, fostering widespread adoption.

Key Trends in the PET-CT Scanner Device Market

• Growing Adoption of Hybrid Imaging Systems:

Hybrid imaging systems, such as PET-CT and PET-MRI, are gaining traction due to their ability to provide comprehensive diagnostic information by combining functional and anatomical imaging. PET-CT systems dominate the market, as seen with GE Healthcare’s Omni PET/CT platform, which uses AI-driven solutions to enhance operational efficiency. These systems allow clinicians to pinpoint abnormalities with greater accuracy, improving patient outcomes in oncology and neurology. The trend toward hybrid imaging reflects the healthcare industry’s shift toward integrated solutions, enabling faster and more precise diagnoses, which is particularly valuable in complex cases like cancer staging or neurological assessments.

• Shift Toward Outpatient Diagnostic Centers:

The rise of outpatient diagnostic centers is reshaping the PET-CT scanner market, driven by the demand for accessible and cost-effective imaging services. These centers, growing rapidly in regions like Asia-Pacific, offer advanced imaging at lower costs compared to hospitals, attracting a broader patient base. For instance, diagnostic centers in India are increasingly adopting mobile PET-CT scanners to serve remote areas, as seen with United Imaging Healthcare’s portable systems introduced in 2019. This trend aligns with the global shift toward patient-centered care, emphasizing convenience and efficiency while reducing the financial burden on healthcare systems.

• Integration of AI and Precision Medicine:

The integration of AI and the focus on precision medicine are transforming the PET-CT scanner market. AI algorithms enhance image analysis, enabling automated detection of abnormalities and personalized treatment planning. For example, United Imaging’s collaboration with AI technologies has improved diagnostic accuracy for their PET-CT systems. Precision medicine, supported by novel radiotracers targeting specific biomarkers, allows tailored therapies, particularly in oncology and neurology. This trend is evident in the growing use of PET-CT for theranostics, where imaging guides personalized treatment, improving outcomes for patients with conditions like Alzheimer’s or cancer, and driving market innovation.

We explore the factors propelling the PET-CT scanner device market growth, including technological advancements, consumer behaviors, and regulatory changes.

Leading companies operating in the global PET-CT Scanner industry:

• Bruker Corporation
• Canon Medical Systems USA, Inc.
• General Electric Company
• Hitachi, Ltd.
• Koninklijke Philips N.V.
• Mediso Inc.
• New Soft Inc.
• Positron Corporation
• Shimadzu Corporation
• Siemens Healthcare GmbH (Siemens AG)
• Sophie Biosciences K.K.
• United Imaging Healthcare, Inc.
• Yangzhou Kindsway Biotechnology Co., Ltd.

PET-CT Scanner Devices Market Report Segmentation:

By Type:

• Stationary scanner
• Portable Scanners/Mobile Scanners

Stationary scanners account for the largest segment due to their high image quality, reliability, and suitability for a wide range of clinical applications.

By number of slices:

• Low-slice scanner (<64-slice)
• Medium Slice Scanner (64 Slices)
• High-Slice Scanner (> 64-slice)

Medium-slice scanners (64 slices) account for the majority of the market share due to their balance between image resolution and cost-effectiveness, making them a popular choice among healthcare professionals.

By Isotope and Detector Type:

• Flurodeoxyglucose (FDG)
• 62Cu ATSM
• 18 F Sodium Fluoride
• FMISO
• gallium
• thallium
• others

Flurodeoxyglucose (FDG) shows a distinct advantage in the market due to its widespread availability, well-established efficacy in cancer imaging, and reimbursement support.

By Service Provider:

• hospital
• Diagnostic Centers
• Research Institutes

Hospitals account for the largest market share by driving comprehensive diagnostic and treatment services, including PET-CT imaging, to a wide patient population.

By Application:

• oncology
• neurology
• cardiology
• others

Oncology dominates the market, which can be attributed to the utilization of PET-CT images in cancer diagnosis, staging, treatment planning, and response assessment.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others)
• Latin America (Brazil, Mexico, and others)
• Middle East & Africa

Asia-Pacific enjoys a leading position in the PET-CT scanner devices market owing to the increasing investments in healthcare infrastructure, rising prevalence of cancer, and increasing adoption of advanced medical imaging technologies.

Research Methodology:

The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact

IMARC Group

134 N 4th St. Brooklyn, NY 11249 United States

E-mail sales@imarcgroup.com

Phone: (D) +91 120 433 0800

USA: +1-631-791-1145